Renovaro will Establish the GEDi CUBE Next Generation Nvidia Blackwell Cluster with Nebul's certified AI Healthcare Cloud solutionsLOS ANGELES, ...

Grail needs time to establish its liquid biopsy testing approach in the marketplace, and most importantly, to ensure its ...

AI-driven tools for prescreening patients, predicting responses and outcomes, and guiding patient therapy are maturing and entering the market.

Luis E. Raez, MD, discusses the current liquid biopsy options for patients with lung cancer through assessing circulating tumor DNA. Luis E. Raez, MD, medical director and chief scientific officer at ...

Guardant Health (GH) announced a collaboration with Boehringer Ingelheim to pursue the regulatory approval and commercialization of the ...

From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.

This past year, the role of ctDNA testing has expanded to guide treatment decisions for providers and patients with cancer.

We recently published a list of Billionaire Stanley Druckenmiller’s Top 10 Stock Picks. In this article, we are going to take ...

Abu Dhabi health chiefs have hailed the introduction of a blood test for colon cancer as a "game-changer" in the emirate's ...

Megan Paulette Rosales Nacar, VP of commercial at DeciBio, is a leader in precision medicine and oncology, driving commercial ...

For instance, positive biopsy results would likely result in recommended interventions and additional genomic testing.

A new screening method that combines laser analysis with a type of AI is the first of its kind to identify patients in the ...